Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: October 2019

MissionIRNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Inks LOI with BeneYOU, LLC

Posted on October 10, 2019 by MissionIR

Leading multi-channel lifestyle company Youngevity International (NASDAQ: YGYI) and BeneYOU LLC, a nutritional and beauty products company, this morning announced the execution of a non-binding Letter of Intent (“LOI’) detailing YGYI’s purchase of certain assets of BeneYOU. The companies intend … Continue reading →

Posted in MissionIRNewsBreaks, Youngevity International Inc. YGYI | Leave a comment

Predictive Oncology Inc. (NASDAQ: POAI) Inks its Largest Single-Hospital Sale of Revolutionary STREAMWAY(R) System

Posted on October 9, 2019 by MissionIR

POAI recently announced the sale of 10 FDA-approved, CE-marked STREAMWAY Systems STREAMWAY Systems are the first truly continuous, direct-to drain fluid-disposal solutions designed specifically for medical applications The announcement is another positive indication that POAI subsidiary Skyline Medical offers tremendous qualitative, … Continue reading →

Posted in Lexaria Bioscience Corp. (LXRP) | Leave a comment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) DehydraTECH Featured in Human CBD Study Results Published in Clinical Journal

Posted on October 9, 2019 by MissionIR

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, announced that final study results of a 2018 clinical study evaluating the use of its proprietary drug-delivery system have been published (http://ibn.fm/AYzRL) (http://ibn.fm/PfnAA). Published in Advances in Therapy, … Continue reading →

Posted in Lexaria Bioscience Corp. (LXRP) | Leave a comment

MissionIRNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Plans to Present at Inaugural MicroCap Rodeo Investor Conference

Posted on October 9, 2019 by MissionIR

Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) today announced its plans to present at the upcoming inaugural MicroCap Rodeo Investor Conference to be held at the Hilton Austin – Downtown in Austin, Texas. Genprex’s presentation is scheduled to take place … Continue reading →

Posted in Genprex Inc. GNPX, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Posts Credit Financing Update

Posted on October 9, 2019 by MissionIR

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified-organic cannabis, today announced that it is reviewing alternative financing options to complete construction at its facilities in Ancaster, Ontario and phase 1a at Valleyfield, Quebec. … Continue reading →

Posted in MissionIRNewsBreaks, The Green Organic Dutchman Holdings Ltd. TGODF | Leave a comment

Predictive Oncology Inc. (NASDAQ: POAI) Continues to Innovate to Improve Outcomes for Cancer Patients

Posted on October 8, 2019 by MissionIR

POAI is leveraging the potential of AI and smart tumor profiling to predict tumor drug response TumorGenesis is developing innovative techniques for growing tumors in laboratory settings Helomics uses vital information from patients’ own living tumors to assist oncologists in … Continue reading →

Posted in Predictive Oncology Inc. POAI | Leave a comment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Riding High on Potential Cannabis, Nicotine Uses of Patented Technology

Posted on October 8, 2019 by MissionIR

Lexaria Bioscience is helping to revolutionize efforts to provide common drug substances in an ingestible method that avoids unhealthy practices such as inhaled smoking or vaping Lexaria’s DehydraTECH platform works to deliver the chemical compounds to the blood stream at … Continue reading →

Posted in Lexaria Bioscience Corp. (LXRP) | Leave a comment

MissionIRNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) to Present at Second Annual Advances in Immuno-Oncology USA Congress and World Immunotherapy Congress

Posted on October 8, 2019 by MissionIR

INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced that its Co-Founder and CEO RJ Tesi, M.D., will present at the 2nd Annual Advances in … Continue reading →

Posted in INmune Bio Inc. INMB, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Provides R&D Program Update

Posted on October 8, 2019 by MissionIR

Global innovator in drug delivery platforms Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today provided an update on the ongoing relationship and pursuit of innovation in oral, reduced risk nicotine consumer products using Lexaria’s patented DehydraTECH(TM) technology. According to the … Continue reading →

Posted in Lexaria Bioscience Corp. (LXRP), MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Portfolio Company Receives Health Canada Approval for Facility Expansion

Posted on October 8, 2019 by MissionIR

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Monday announced that its portfolio company TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) has gained Health Canada approval for a significant expansion at its Mississauga, Ontario facility. … Continue reading →

Posted in Canopy Rivers Inc. CNPOF, MissionIRNewsBreaks | Leave a comment